Strong Independent Association of TILs with OS for Patients with ERBB2-positive Early Breast Cancer By Ogkologos - February 26, 2025 757 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from updated analysis of the ShortHER study Source RELATED ARTICLESMORE FROM AUTHOR Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics with a favourable safety profile Anito-cel, a d-Domain BCMA CAR T-Cell, Induces Rapid, Deep, and Durable Responses in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Relacorilant MOST POPULAR Aiming to Prevent Cancer Cases, ESMO Calls Against Misleading Alcohol-Labelling Following... December 3, 2025 How Does Smoking Increase Your Cancer Risk? An Expert Q&A July 27, 2021 Singer Surprises 6-Year-Old Fan Who Beat Cancer With Trip To Disney January 10, 2022 Latest episode of our podcast for researchers May 23, 2022 Load more HOT NEWS Breast cancer mortality down 66% in 20 years FDA Grants Traditional Approval to Pirtobrutinib for Chronic Lymphocytic Leukaemia and... Lorlatinib in First-Line Treatment of Patients with Advanced ALK-Positive NSCLC With... Gynaecological Cancers: Immunotherapy and Novel Targeted Drug Appear Beneficial in Group...
